• Facebook
  • Twitter
PHYSIDIA
  • PATIENTS
    • > Renal insufficiency
    • > Home haemodialysis
    • > Physidia services
    • > Testimonial
    • > FAQ
  • PROFESSIONALS
    • > Benefits of daily haemodialysis
    • > SeCoHD therapy
    • > Our products
    • > Tools and trainings
    • > Testimonials
    • > FAQ
  • ABOUT US
    • > Our team
    • > Our commitments and mission
    • > Physidia network
    • > Video presentation
  • NEWS
  • CONTACT
Select Page
β2M removal – a study on middle molecules elimination with home hemodialysis

β2M removal – a study on middle molecules elimination with home hemodialysis

by Jean-Paul Haber | Mar 12, 2021 | News

SINGLE SESSION and WEEKLY BETA 2 MICROGLOBULIN REMOVAL DURING SHORT FREQUENT HEMODIALYSIS USING PHYSIDIA TECHNOLOGY Physidia publication at the 2021 ADC conference β2M removal – a study on efficiency of middle molecules elimination with short frequent hemodialysis The...

Recent Posts

  • The Physidia – Spindial partnership has been awarded the frequent home hemodialysis tender issued by the Tuscany region in Italy
  • WEBINAR THE FUTURE IS AT HOME
  • Physidia ISHD 2021 Hemodialysis virtual Showcase
  • Physidia Symposium UK dialysis conference 2021 Solution for frequent home Hemodialysis
  • Physidia and Spindial annonce their Partnership Italian and European Market

Recent Comments

    Archives

    • July 2022
    • October 2021
    • September 2021
    • August 2021
    • June 2021
    • May 2021
    • March 2021
    • July 2019
    • June 2019
    • May 2019
    • September 2018

    Categories

    • La dialyse à domicile-en
    • News
    • Non classé
    • Produits-en

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • Homepage
    • Patients
    • Professionals
    • About us
    • News
    • Contact
    • Legals
    • Facebook
    • Twitter
    Design by koobalibre.fr